PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis

@article{Ili2011PI3KtargetedTC,
  title={PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis},
  author={N. Ili{\'c} and T. Utermark and H. Widlund and T. Roberts},
  journal={Proceedings of the National Academy of Sciences},
  year={2011},
  volume={108},
  pages={E699 - E708}
}
  • N. Ilić, T. Utermark, +1 author T. Roberts
  • Published 2011
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences
  • The PI3K pathway is frequently activated in cancer; therefore, considerable effort is focused on identifying compounds that can inhibit specific pathway components, particularly the hallmark oncogene PIK3CA. Although targeted inhibition of a cancer survival gene holds significant promise, there are concerns that drug resistance may emerge within the cancerous cells, thus limiting clinical efficacy. Using genetically defined human mammary epithelial cells, we evolved resistance to the PI3K… CONTINUE READING
    MYC on the Path to Cancer
    • 1,673
    • Open Access
    PI3K and cancer: lessons, challenges and opportunities
    • 1,025
    • Open Access
    The PI3K Pathway in Human Disease
    • 483
    • Open Access
    MYC, Metabolism, and Cancer.
    • 419
    • Open Access
    Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    • 180
    • Open Access
    eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
    • 123
    • Open Access
    Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.
    • 138
    • Open Access
    RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.
    • 85
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 63 REFERENCES
    PI3K pathway alterations in cancer: variations on a theme
    • 1,557
    • Highly Influential
    • Open Access
    Oncogenic pathway signatures in human cancers as a guide to targeted therapies
    • 1,819
    • Open Access
    Mutant PIK3CA promotes cell growth and invasion of human cancer cells.
    • 775
    • Highly Influential
    • Open Access